Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test could revolutionize cancer monitoring in Brazil's public health system

NCT ID NCT06640283

First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 21 times

Summary

This study is testing a new, low-cost blood test that looks for tumor DNA from HPV-related cancers (cervical and anal) after standard radiation treatment. The goal is to see if this simple test can replace expensive scans and biopsies for monitoring patients, and to identify those at high risk of recurrence who might benefit from early immunotherapy. The study involves 150 participants in Brazil's public health system.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV-RELATED CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto do Câncer do Estado de São Paulo - ICESP

    RECRUITING

    São Paulo, 01246-000, Brazil

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.